Micropolis Receives Notification from NYSE American Regarding Delayed Annual Report Filing
Rhea-AI Summary
Micropolis AI Robotics (NYSE American: MCRP) received a NYSE American notice on May 18, 2026 for not timely filing its 2025 Form 20-F, due May 15, 2026.
The company has until November 15, 2026 to cure the delinquency, with a potential additional six-month cure period before any suspension or delisting. Shares continue trading during the cure period.
AI-generated analysis. Not financial advice.
Positive
- Initial cure period through November 15, 2026 to file 2025 Form 20-F
- Potential additional six-month cure period through May 15, 2027 at Exchange discretion
- Ordinary shares continue to trade on NYSE American during cure period
- Company working with auditors and advisors to complete 2025 Form 20-F
Negative
- Company is not in compliance with NYSE American continued listing standards
- 2025 Form 20-F filing delayed due to ongoing audit-related matters
- Risk of suspension and delisting if filings are not cured within allowed period
- No assurance the company will regain full compliance with listing standards
News Market Reaction – MCRP
On the day this news was published, MCRP declined 0.99%, reflecting a mild negative market reaction. Argus tracked a trough of -2.4% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $912K from the company's valuation, bringing the market cap to $91.17M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: HUBC in scanner was up 10.58%, while MLGO and UBXG were down 5.36% and 15.50%. With sector momentum flagged and MCRP down 3.1%, today’s weakness reflects both company-specific listing risk and broader volatility.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 08 | Recognition & contract | Positive | +0.8% | UAE tech recognition and $1.2M EMSTEEL robot agreement announcement. |
| May 07 | Commercial agreement | Positive | -2.9% | Announcement of $1.2M EMSTEEL deployment deal for four robots. |
| May 04 | Product launch | Positive | +6.6% | Unveiling of next‑gen M1.5 hybrid autonomous robot at industry exhibition. |
| Apr 23 | Strategic agreement | Positive | -3.1% | Engineering and manufacturing agreement with DP World for automation solutions. |
| Apr 07 | Conference participation | Positive | -1.6% | Participation in Maxim Group AI Infrastructure Virtual Conference fireside chat. |
Recent operational and recognition news has produced mixed reactions, with more divergences than alignments between positive headlines and price moves.
Over the past six weeks, Micropolis reported multiple positive operational updates, including a USD $1.2 million EMSTEEL agreement on May 7 and a high-endurance robot launch on May 4, plus recognition as a leading UAE tech success story on May 8. Earlier, a DP World automation agreement and an AI conference appearance were also disclosed. Price reactions alternated between gains and declines, indicating inconsistent follow-through. Against that backdrop, this NYSE American delinquency notice introduces a distinctly regulatory/compliance risk not present in prior news.
Market Pulse Summary
This announcement highlighted NYSE American’s notice that Micropolis missed the May 15, 2026 deadline for its 2025 Form 20-F, triggering an Initial Cure Period through November 15, 2026 and a possible extension to May 15, 2027. It adds a regulatory and reporting‑quality overhang to a story previously driven by contracts and product launches. Investors may monitor filing progress, any subsequent NYSE communications, and how these interact with existing financing structures and significant shareholdings.
Key Terms
form 20-f regulatory
nyse american regulatory
form 12b-25 regulatory
schedule 13g regulatory
form 144 regulatory
424b3 regulatory
form 6-k regulatory
convertible promissory note financial
AI-generated analysis. Not financial advice.
Dubai, UAE, May 19, 2026 (GLOBE NEWSWIRE) -- Micropolis AI Robotics (NYSE American: MCRP) today announced that it received a notice from NYSE Regulation on May 18, 2026 indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”). The Company failed to timely file its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the “2025 Form 20-F”) by the filing due date of May 15, 2026 (the “Filing Delinquency”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide.
NYSE Regulation notified the Company that NYSE American will closely monitor the status of the Company’s 2025 Form 20-F and any subsequent delayed filings for a six-month period from the date of the Filing Delinquency until November 15, 2026 (the “Initial Cure Period”). If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company’s securities to be traded for up to an additional six-month period through May 15, 2027 (the “Additional Cure Period”) depending on the Company’s specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 of the NYSE American Company Guide. If the Exchange determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file the 2025 Form 20-F and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.
As disclosed in the Form 12b-25 filed by the Company on April 29, 2026, the Company was unable, without unreasonable effort or expense, to file its 2025 Form 20-F as a result of a delay in completing the audit of its financial statements for the fiscal year ended December 31, 2025. The delay is due to certain ongoing audit-related matters that require additional time to resolve. The Company is working diligently with its auditors and advisors to complete the 2025 Form 20-F and intends to file within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.
The delinquency notice has no immediate impact on the listing of the Company’s ordinary shares, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.
About Micropolis AI Robotics
Micropolis is a robotics manufacturer founded in 2014, based in UAE with its headquarters located in Dubai Production City, Dubai, UAE. It specializes in developing AMRs that utilize wheeled EV platforms and are equipped with autonomous driving capabilities. As part of Micropolis’ product offerings, it integrates application-specific pods that serve as the primary purpose of a robot. These pods are designed to accommodate various functionalities, including surveillance cameras, road sweepers, logistics compartments, as well as collaborative robots (cobots) intended for direct human-robot interaction.
Safe Harbor Statement
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.
Contact Information
For Investor Relations:
Micropolis AI Robotics
Email: Francesca@micropolis.ae
